These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 3589686)

  • 1. The intracavitary administration of cytarabine to patients with nonhematopoietic malignancies: an update.
    Markman M; Howell SB
    Semin Oncol; 1987 Jun; 14(2 Suppl 1):116-20. PubMed ID: 3589686
    [No Abstract]   [Full Text] [Related]  

  • 2. The intracavitary administration of cytarabine to patients with nonhematopoietic malignancies: pharmacologic rationale and results of clinical trials.
    Markman M
    Semin Oncol; 1985 Jun; 12(2 Suppl 3):177-83. PubMed ID: 3892699
    [No Abstract]   [Full Text] [Related]  

  • 3. Combination intraperitoneal chemotherapy with cisplatin, cytarabine, and doxorubicin for refractory ovarian carcinoma and other malignancies principally confined to the peritoneal cavity.
    Markman M; Howell SB; Lucas WE; Pfeifle CE; Green MR
    J Clin Oncol; 1984 Dec; 2(12):1321-6. PubMed ID: 6542584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intraperitoneal chemotherapy with high-dose cisplatin and cytosine arabinoside for refractory ovarian carcinoma and other malignancies principally involving the peritoneal cavity.
    Markman M; Cleary S; Lucas WE; Howell SB
    J Clin Oncol; 1985 Jul; 3(7):925-31. PubMed ID: 3894586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ip chemotherapy employing a regimen of cisplatin, cytarabine, and bleomycin.
    Markman M; Cleary S; Lucas W; Weiss R; Howell SB
    Cancer Treat Rep; 1986 Jun; 70(6):755-60. PubMed ID: 2425962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intraperitoneal chemotherapy: introduction into a community hospital.
    Dunn MP; Krzeczowski KA; Courter SG
    Prog Clin Biol Res; 1986; 216():361-5. PubMed ID: 3725799
    [No Abstract]   [Full Text] [Related]  

  • 7. Intraperitoneal cisplatin and cytarabine in the treatment of refractory or recurrent ovarian carcinoma.
    Markman M; Hakes T; Reichman B; Hoskins W; Rubin S; Jones W; Almadrones L; Yordan EL; Eriksson J; Lewis JL
    J Clin Oncol; 1991 Feb; 9(2):204-10. PubMed ID: 1988569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term survival of advanced refractory ovarian carcinoma patients with small-volume disease treated with intraperitoneal chemotherapy.
    Howell SB; Zimm S; Markman M; Abramson IS; Cleary S; Lucas WE; Weiss RJ
    J Clin Oncol; 1987 Oct; 5(10):1607-12. PubMed ID: 2443622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nursing procedures for intraperitoneal administration of cis-platin and Ara-C in the community hospital.
    Olson EZ; Selders NJ
    Prog Clin Biol Res; 1986; 216():367-75. PubMed ID: 3725800
    [No Abstract]   [Full Text] [Related]  

  • 10. Melphalan and cytarabine administered intraperitoneally as single agents and combination intraperitoneal chemotherapy with cisplatin and cytarabine.
    Markman M
    Semin Oncol; 1985 Sep; 12(3 Suppl 4):33-7. PubMed ID: 4048974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intrapleural cisplatin and cytarabine in the management of malignant pleural effusions: a Lung Cancer Study Group trial.
    Rusch VW; Figlin R; Godwin D; Piantadosi S
    J Clin Oncol; 1991 Feb; 9(2):313-9. PubMed ID: 1988578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First experiences with intraperitoneal chemotherapy in ovarian cancer.
    Gitsch E; Sevelda P; Schmidl S; Salzer H
    Eur J Gynaecol Oncol; 1990; 11(1):19-22. PubMed ID: 2347331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic effect of combined intraperitoneal cisplatin and cytosine arabinoside in a murine ovarian cancer model.
    Berek JS; Schink JC; Knox RM
    Obstet Gynecol; 1989 Oct; 74(4):663-6. PubMed ID: 2797645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemotherapy in ovarian carcinoma: intravenous or intraperitoneal?
    Markman M
    Hematol Oncol Clin North Am; 1988 Sep; 2(3):457-66. PubMed ID: 3053594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surgically documented response to intraperitoneal cisplatin, cytarabine, and bleomycin after intravenous cisplatin-based chemotherapy in advanced ovarian adenocarcinoma.
    Piver MS; Lele SB; Marchetti DL; Baker TR; Emrich LJ; Hartman AB
    J Clin Oncol; 1988 Nov; 6(11):1679-84. PubMed ID: 3183700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Chemotherapy of epithelial ovarian carcinoma].
    Bruntsch U; Gallmeier WM
    MMW Munch Med Wochenschr; 1983 Nov; 125(44):993-5. PubMed ID: 6417517
    [No Abstract]   [Full Text] [Related]  

  • 17. [Adjuvant chemotherapy with cisplatin and cyclophosphamide in FIGO I-II epithelial carcinoma of the ovary: preliminary results].
    Chiara S; Conte PF; Bruzzone M; Falcone A; Rosso R; Ragni N; Bentivoglio G; Foglia G; Pescetto G
    G Ital Chemioter; 1985; 32(1):67-9. PubMed ID: 3830795
    [No Abstract]   [Full Text] [Related]  

  • 18. [Current status and prospects of chemotherapy of ovarian cancer].
    Sen K; Lang JH; Lian LJ
    Zhonghua Fu Chan Ke Za Zhi; 1994 Dec; 29(12):753-7. PubMed ID: 7712905
    [No Abstract]   [Full Text] [Related]  

  • 19. [Chemotherapy of epithelial ovarian cancer: CHexUP versus thio-tepa].
    Wu BZ
    Zhonghua Fu Chan Ke Za Zhi; 1987 Jan; 22(1):5-8, 61. PubMed ID: 3109851
    [No Abstract]   [Full Text] [Related]  

  • 20. [The value of platinum dose intensity in first-line therapy on subsequent disease follow-up of epithelial ovarian carcinoma].
    Gruböck K
    Wien Klin Wochenschr; 1994; 106(11):362-6. PubMed ID: 8053205
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.